Shots: Ascentage will be responsible to sponsor the P-Ib/II trial (NCT03611868) which involves assessing of APG-115 in combination with Keytruda, to evaluate its safety and efficacy in solid tumors (i,e., […]readmore
Tags : Collaboration
Shots: Translate Bio to receive $425M up front consisting $300M in cash and $125M as equity investment at $25.59/ share representing a 50% premium to the 20-day moving average share […]readmore
Shots: AbbVie collaborated with Harbour BioMed (HBM), Utrecht University (UU) and Erasmus Medical Center (EMC) to develop a novel Ab to prevent and treat COVID-19. The collaboration focuses on advancing […]readmore
Shots: Under the amended agreement, Intellia to receive ~$70M as up front with an additional equity investment of $30M at $32.42/ share. The 2016 collaboration get extended until April 2024 […]readmore
Shots: Vanda will collaborate with UW Medicine and its Virology Lab on a pharmacogenetics study in patients with COVID-19. The study will focus on the sequencing of the genome of […]readmore
Shots: Blackstone to invest $2B in Alnylam that includes $1B in committed payments in exchange of 50% royalties and commercial milestones for inclisiran, ~$750M in a first lien senior secured […]readmore
Shots: The clinical research commences in NIH-led Adaptive COVID-19 Treatment Trial and will evaluate the efficacy and safety of baricitinib for hospitalized patients diagnosed with COVID-19, initiating this month in […]readmore
Shots: NeoImmuneTech to sponsor the trial and BMS will supply Opdivo (nivolumab) for the use in the trial. Additionally, under Master Clinical Trial Collaboration Agreement, the first study will be […]readmore
Shots: BioNTech to receive $185M up front, including $72M cash & $113M equity investment, up to $563M as milestone making a total deal value $748M. The companies will equally share […]readmore
Shots: Sanofi has finalized the planned Praluent (alirocumab) restructuring with Regeneron. The new agreement is effective from Apr 01, 2020 that simplify the Ab collaboration b/w the companies, increases efficiency […]readmore